期刊文献+

鸡传染性法氏囊病病毒超强株VP2基因重组新城疫病毒胚胎免疫安全性及效力试验 被引量:6

Safety and efficacy of a recombinant Newcastle disease virus expressing the VP2 gene of very virulent infectious bursal disease virus
在线阅读 下载PDF
导出
摘要 为研制能够同时预防传染性法氏囊病(IBD)和新城疫(ND)的疫苗,本研究选用表达IBD病毒(IBDV)超强毒株(vvIBDV)VP2基因的重组ND病毒(NDV)LaSota疫苗株(rL-VP2),测定其半数鸡胚感染量、平均鸡胚致死时间、脑内接种指数和静脉内致病指数等指标,按不同剂量接种18胚龄SPF鸡胚,分别于出雏后第9d、第14d和第21d采血,用微量凝集法和ELISA方法测定血清中抗NDV抗体和抗IBDV抗体水平,并于出雏后28d用NDV强毒(F48E9株)和vvIBDVGx株攻毒,评估重组疫苗的胚胎免疫效果。结果显示:按104EID50/枚剂量进行免疫不会影响SPF鸡胚出雏率和出雏后21d存活率,并且该免疫组雏鸡能够对NDV强毒和vvIBDV攻毒提供安全的免疫保护。 The recombinant Newcastle disease virus (NDV) (rL-VP2) expressing the VP2 gene of very virulent infectious bursal disease virus (vvIBDV) Gx strain as a candidate vaccine was evaluated. The vaccine was administered to 18 day old SPF chicken embryos with different doses and antibody titers were detected at 9,14 and 21 days post hatching. The results showed that the vaccine did not hamper hatching or surviving post hatching when rL-VP2 was administered with 104 EID50/egg dosage. The rL-VP2 vaccination could completely protect chickens against the NDV F48E9 strain and vvIBDV Gx strain challenge at four weeks post-hatch.
出处 《中国预防兽医学报》 CAS CSCD 北大核心 2010年第9期695-698,共4页 Chinese Journal of Preventive Veterinary Medicine
基金 国家科技支撑计划(2006BAD06A16) 国家科技支撑计划(2006BAD06A05)
关键词 胚胎免疫 重组新城疫病毒 传染性法氏囊病毒超强毒株 VP2基因 in ovo vaccination recombinant Newcastle disease virus very virulent Infectious bursal disease virus VP2 gene
  • 相关文献

参考文献13

  • 1WANGXiao-mei,FUChao-yang,GAOHong-lei,SONGXiou-long,ZENGXiang-wei,ZHANGMan-fu,WallaceBLlim.Pathogenic Antigenic and Molecular Characterization of the Very Virulent Strain(Gx) of Infectious Bursal Disease Virus Isolated in China[J].Agricultural Sciences in China,2003,2(5):566-572. 被引量:15
  • 2Ge J Y,Deng G H,Wen Z Y,et al.Newcastle disease virus-based live attenuated vaccine completely protects chickens and mice from lethal challenge of homologous and heterologous H5N1 avian influenza viruses[J].J Virol,2007,1(81):150-158.
  • 3吴祥辉,刘向萍.蛋内注射技术——家禽免疫新视点[J].中国家禽,2004,26(17):31-36. 被引量:3
  • 4Li C S,Wang L Y,Chou C C.Field evaluation of flock production performance of in ovo injection of infectious bursal disease virus immune complex vaccine in commercial broiler farms[J].Poultry Sci,2005,14:338-344.
  • 5Saravandava K,Nachimuthu K,Padmanaban V D.Effect of tuftsin on embryo vaccination with newcastle disease virus vaccine[J].Comp Microbiol Infect Dis,2005,28:269-276.
  • 6Giambrone J J,Dormitorio T,Brown T.Safety and efficacy of in ovo administration of infectious bursal disease viral vaccines[J].Avian Dis,2001,45:144-148.
  • 7Tobias L,Fasseli C,Felix A R,et al.Molecular and structural bases for the antigenicity of VP2 of infectious bursal disease virus[J].J Virol,2007,81(23):12827-12835.
  • 8Sheppard M,Werner W,Johnson M,et al.Fowl adenovirus recombinant expressing VP2 of infectious bursal disease virus induces protective immunity against bursal disease[J].Arch Virol,1998,143:915-930.
  • 9Tsukamoto K,Saito S,Samaguchi S,et al.Complete,long-lasting protection against lethal infectious bursal disease virus challenge by a single vaccination with an avian herpesvirus vector expressing VP2 antigens[J].J Virol,2002,76:5637-5645.
  • 10Heine H G,Boyle D B.Infectious bursal disease virus structural protein VP2 expressed by a fowlpox virus recombinant confers protection against disease in chickens[J].Arch Virol,1993,131:277-292.

二级参考文献19

共引文献21

同被引文献51

引证文献6

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部